Vesugen 20mg

THIS PRODUCT IS INTEDED AS A RESEARCH CHEMICAL ONLY.
This designation allows the use of research chemicals strictly in vitro for testing and laboratory experimentation only. All products information available on this website is for educational purposes only. Bodily introduction of any kind into humans or animals is strictly forbidden by law. This product should only be handled by licensed, qualified professional. This product is not a drug, food or cosmetic and may not be misbranded, misused or mislabled as a drug food or cosmetic.

Vesugen 20mg                 

Vesugen is a synthetic ultra-short tripeptide bioregulator composed of the amino acid sequence Lys-Glu-Asp (KED). It belongs to the family of Khavinson peptide bioregulators, a group of tissue-specific peptides originally developed at the St. Petersburg Institute of Bioregulation and Gerontology for investigating cellular aging, vascular biology, and tissue-specific gene regulation. Vesugen is primarily studied in vascular endothelial biology, cardiovascular research, microcirculation, regenerative medicine, and healthy aging, where it serves as an investigational tool for understanding endothelial cell function and vascular homeostasis.

Unlike conventional peptide hormones that primarily bind membrane receptors, Vesugen is proposed to function through molecular bioregulation. Experimental studies suggest that ultra-short peptides such as KED may interact with chromatin-associated proteins and DNA promoter regions, potentially influencing tissue-specific gene expression involved in cellular maintenance, proliferation, and repair. Laboratory docking studies have examined interactions with promoter regions of genes such as MKI67 (Ki-67), a marker associated with cellular proliferation. While these proposed mechanisms remain under investigation, they have made Vesugen an important research compound in molecular biology and epigenetics.

One of the primary areas of scientific investigation involves vascular endothelial cell biology. Experimental cell culture studies have reported that Vesugen may influence endothelial cell proliferation, reduce apoptosis, and support endothelial renewal through modulation of molecular markers such as Ki-67 and p53. Researchers continue to investigate how these mechanisms contribute to vascular maintenance, endothelial integrity, and age-related changes in blood vessels. However, these observations remain largely preclinical, and additional independent studies are needed to further validate the proposed biological effects.

Researchers have also investigated Vesugen in studies involving microcirculation, extracellular matrix remodeling, vascular smooth muscle biology, oxidative stress, and healthy vascular aging. Experimental models continue to examine how endothelial signaling influences tissue oxygenation, vascular remodeling, inflammatory responses, and cellular adaptation during aging. Because endothelial dysfunction plays an important role in numerous cardiovascular conditions, Vesugen remains an active area of investigation within vascular research.

Beyond cardiovascular biology, Vesugen has attracted scientific interest in studies involving cellular aging, regenerative medicine, neurovascular biology, and peptide engineering. Scientists continue to evaluate how tissue-specific peptide bioregulators influence chromatin organization, transcriptional regulation, and cellular resilience throughout the aging process. Despite promising laboratory findings, Vesugen remains strictly an investigational research peptide with no approved therapeutic indications.

Areas of Scientific Research

Vesugen continues to be investigated in laboratory studies involving:

• Vascular endothelial biology
• Endothelial cell proliferation
• Tissue-specific peptide bioregulation
• Gene expression and epigenetic regulation
• Microcirculation research
• Vascular remodeling
• Smooth muscle biology
• Cellular aging and longevity research
• Oxidative stress and antioxidant pathways
• Angiogenesis research
• Regenerative medicine
• Molecular bioregulation
• Cardiovascular physiology
• Peptide engineering

These ongoing investigations continue to improve scientific understanding of endothelial biology, vascular homeostasis, and tissue-specific molecular regulation. Current evidence remains primarily preclinical.

Product Quality

Vesugen 20mg is supplied as a lyophilized (freeze-dried) powder, a formulation widely used in peptide research because it preserves molecular stability during transportation and long-term laboratory storage. Lyophilization minimizes moisture-related degradation while maintaining peptide integrity until reconstitution according to laboratory protocols. High-quality research Vesugen is commonly verified using High-Performance Liquid Chromatography (HPLC) and Mass Spectrometry (MS) to confirm peptide identity, purity, and batch consistency.

This product is intended exclusively for laboratory and scientific research. It is not intended for human consumption, therapeutic use, or veterinary applications.